Latest News
Dogwood Therapeutics, Inc.
- A 4.1M-share sale by Dogwood Therapeutics (DWTX) is expected to close by October 29.
- Dogwood Therapeutics Raises $5 Million From Largest Shareholder CK Life Sciences
- Dogwood Therapeutics Raises $5 Million From Sealbond at $1.22; Grants Registration Rights
- Dogwood Therapeutics secures $5M investment from largest shareholder; shares rise
- Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
- A $5 million investment is expected to fund Dogwood through March 2027 as it plans its next pain-drug trial.
- Dogwood Therapeutics, Inc. announced that it expects to receive $4.999999 million in funding from Sealbond Limited
- Here's Why Dogwood Therapeutics (NASDAQ:DWTX) Must Use Its Cash Wisely
- Dogwood to Participate in the 2026 Maxim Growth Summit
- Pain-drug trial results are expected in November; Dogwood will meet investors at a New York summit.
Headlines from the last 30 days, linking to the original publishers. See all market news →